Clinical Trial Update: Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating hydroxyzine for anxiety in underweight patients with anorexia nervosa or eating disorder not otherwise specified has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia Nervosa
• Anxiety Disorders
• Eating Disorders

Drugs mentioned

• Hydroxyzine (hydroxyzine)

Snippet

Sponsor: HealthPartners Institute | Conditions: Anxiety in Those Patients With Anorexia Nervosa, Eating Disorder Not Otherwise Specified, BMI (<=18) | Phase 4 | Status: WITHDRAWN